Hi-Fidelity Fill/Finish for Biologics: Drug efficacy, reputation, and financial return are all on the line when it comes to fill/finish.

The article focuses on the challenges and innovations in aseptic fill/finish processes for biologics, and it emphasizes the complexity and fragility of these therapies and their growing importance in the global biologics market. It reports on the adoption of robotic isolators to enhance safety and quality, the shift toward barrier systems in cleanroom installations, and the need to minimize product loss, increase efficiency, and address environmental concerns in fill/finish operations.